NEW PHARMACEUTICAL FORMULATION
MX434749BActive Publication Date: 2026-06-12F HOFFMANN LA ROCHE & CO AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MX2022001159
- Authority / Receiving Office
- MX · MX
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-07-31
- Filing Date
- 2022-01-27
- Publication Date
- 2026-06-12
- Estimated Expiration
- 2040-07-29
Abstract
This document discloses pharmaceutical compositions and dosage forms that include N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide, which are useful in the treatment of subjects with cancer. This disclosure further provides procedures for the preparation of these pharmaceutical compositions and dosage forms, and procedures for treating subjects with cancer using the pharmaceutical compositions and dosage forms provided herein.
Need to check novelty before this filing date? Find Prior Art